Zomedica/ZOM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Zomedica

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Ticker

ZOM

Sector

Healthcare

Trading on

AMEX

Industry

Fish/Livestock

CEO

Larry Heaton

Employees

144

Headquarters

Ann arbor, United States

Zomedica Metrics

BasicAdvanced
$163M
Market cap
-
P/E ratio
-$0.04
EPS
0.88
Beta
-
Dividend rate
$163M
0.88138
$0.25
$0.12
5.6M
11.497
10.865
-14.26%
-15.07%
-14.73%
6.291
0.704
1.414
25.68%
-91.60%

What the Analysts think about Zomedica

Analyst Ratings

Majority rating from 1 analysts.
Buy

Zomedica Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-146.77% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$6.2M
-15.07%
Net income
-$9.1M
-59.38%
Profit margin
-146.77%
-52.17%

Zomedica Earnings Performance

No data availble
Quarterly data is not available. You can look at the annual data instead.

Earnings per share (EPS)

Company profitability
-
QuarterlyAnnual
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Zomedica stock?

Zomedica (ZOM) has a market cap of $163M as of June 20, 2024.

What is the P/E ratio for Zomedica stock?

The price to earnings (P/E) ratio for Zomedica (ZOM) stock is 0 as of June 20, 2024.

Does Zomedica stock pay dividends?

No, Zomedica (ZOM) stock does not pay dividends to its shareholders as of June 20, 2024.

When is the next Zomedica dividend payment date?

Zomedica (ZOM) stock does not pay dividends to its shareholders.

What is the beta indicator for Zomedica?

Zomedica (ZOM) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Zomedica stock price target?

The target price for Zomedica (ZOM) stock is $0.44, which is NaN% below the current price of $. This is an average based on projections from 1 analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Zomedica stock

Buy or sell Zomedica stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing